Category:

Laura Joszt, assistant managing editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Laura Joszt, assistant managing editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Kelly Walsh, PTNN. This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Kelly Walsh, PTNN. This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Analyses of data from 195 clinical trials show that financial ties between researchers and the pharmaceutical industry were associated with a 3.57 greater odds of a positive trial outcome...Clinical trials involving principal investigators with financial ties to the pharmaceutical industry are more likely to report positive results...The researchers...say their findings — which held even after accounting for the influence of study sponsorship — suggest that financial ties could be leading to bias in the clinical evidence base...Given the importance of industry and academic collaboration in advancing the development of new treatments, more thought needs to be given to the roles that investigators, policy makers, and journal editors can play in ensuring the credibility of the evidence base...

Brian Bobby, PTNN. This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

IBM Watson is to work with the FDA to investigate the use of blockchain technology, seen as one of the most secure ways of sharing patient data...(it) allows each separate patient data source to be a ‘block’ part of a complete, unalterable patient data profile which can then be shared securely with healthcare providers or research organisations...Initially focused on oncology-related data, the collaboration will look at how best to exchange data gathered from multiple owner mediated data sources such as Electronic Medical Records, clinical trials, genomic data, mobile devices, wearables, and Internet of Things technologies...The deal aims to overcome the limitations of large scale sharing of health data seen in the past, namely data security and patient privacy concerns during the data exchange process.

Kelly Walsh, PTNN. This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Laura Joszt, assistant managing editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

Citing burdens on clinicians that could lead to treatment delays, the Joint Commission said its ban on doctors using text messages to order treatments will stay in place for the time being...The Joint Commission...with the Centers for Medicare & Medicaid Services...are working out guidelines for how doctors can use messaging apps and texting to make orders...a number of concerns that led to the decision:

• Using texts or other messaging apps to order treatments could increase the burden on nurses or other clinical staff who would be responsible for inputting such data into electronic health records
• Talking in-person allows for easier clarifications if there are questions about an order, and allows for better confirmation of directives
• ...any clinical decision support alerts triggered during the EHR process, the clinician inputting the information into the system will have to take time to contact the ordering physician to resolve the issue, potentially causing treatment delays